Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2021
Jazz Pharmaceuticals completes acquisition of GW Pharmaceuticals
Jazz Pharmaceuticals announced that it completed its acquisition of GW Pharmaceuticals.
2021
Jazz Pharmaceuticals announces acquisition of GW Pharmaceuticals
Jazz Pharmaceuticals and GW Pharmaceuticals announced a definitive agreement for Jazz to acquire GW for $220 per American Depositary Share, in a transaction valued at $7.2 billion. The transaction was subject to shareholder, court and regulatory approvals and was expected to close in the second quarter of 2021.